NIH-funded research Career grant

Understanding how immune cells affect blood flow and oxygen in stroke patients

Official title: Defining the Spatiotemporal Underpinnings of Neutrophil Recruitment, Microvascular Flow, and Oxygenation in Ischemic Stroke

Funded at State University New York Stony Brook · NIH-10999436 · Data updated 2026-11-12

This study is looking at how certain immune cells called neutrophils behave after a stroke when blood flow returns to the brain, using mice to help us understand how these cells might cause problems like tissue damage, with the hope of finding better treatments for people who have had a stroke.

Quick facts

Grant typeCareer grant
Study typeNIH-funded research
Funding institutionState University New York Stony Brook
NIH-funded
Lab location1 site (Stony Brook, United States)
Project startJanuary 1, 2023
Project endDecember 31, 2027
Funding year2025
Award (this year)$276,085
NIH project number5K08NS121597-03
Project IDNIH-10999436 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals who have experienced an ischemic stroke, particularly those with large vessel occlusion.

Less likely to help

Patients who have not experienced a stroke or those with hemorrhagic stroke may not benefit from this research.

What this research studies

This research investigates the role of immune cells, specifically neutrophils, in the aftermath of ischemic stroke, where blood flow is restored to the brain. By using a mouse model that mimics human stroke conditions, the study aims to identify how these immune cells contribute to complications like microvascular obstruction and tissue damage. Advanced imaging and histopathological techniques will be employed to track the behavior of neutrophils over time, providing insights that could lead to improved treatments for stroke patients.

Why it matters

Potential benefit: If successful, this research could lead to new therapies that reduce disability and improve recovery outcomes for stroke patients.

How similar studies have gone: While preclinical studies have shown promise in blocking neutrophil recruitment, similar approaches have not yet succeeded in human trials, making this research both challenging and potentially groundbreaking.

Where this research is happening

  • State University New York Stony Brook
    Stony Brook, United States
    Active

Researchers

  • Principal investigator: Nadkarni, Neil Avadhoot — State University New York Stony Brook
  • Study coordinator: Nadkarni, Neil Avadhoot

Related research

Other NIH-funded projects on the same topics.

  • Improving blood flow after stroke by breaking down NETs

    Aims to see if breaking down neutrophil extracellular traps (NETs) after an ischemic stroke can improve blood flow and reduce brain injury in patients.

    NIH research Icahn School of Medicine at Mount Sinai · New York, United States · NIH-11606640

  • EP2 blockers to protect the brain after a stroke

    Aims to test brain-permeable EP2 antagonists to reduce damage after ischemic stroke and improve recovery.

    NIH research University of Tennessee Health Sci Ctr · Memphis, United States · NIH-11548335

  • Genetic testing to find causes of early-onset ischemic stroke

    This project uses whole-exome sequencing to look for gene changes that may cause ischemic stroke in adults who had a stroke at a young age.

    NIH research Baltimore VA Medical Center · Baltimore, United States · NIH-11510007

  • Targeted nanomedicine to protect the brain after stroke

    A targeted drug-delivery approach aims to boost blood-brain barrier repair and reduce brain damage after an acute ischemic stroke in patients at risk.

    NIH research Temple Univ of the Commonwealth · Philadelphia, United States · NIH-11504265

  • How biological aging and blood proteins relate to thinking after a stroke

    This project looks at whether measures of biological aging and patterns of blood proteins help explain which stroke survivors keep their thinking sharp and which go on to develop vascular dementia.

    NIH research University of Florida · Gainesville, United States · NIH-11470695

  • Repurposing NEXLETOL to treat ischemic stroke

    Aims to see if the cholesterol drug NEXLETOL can help people after an ischemic stroke by supporting brain energy use and reducing injury.

    NIH research Tulane University of Louisiana · New Orleans, United States · NIH-11468414

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.